07Dec
Private Equity Dealmakers Guidebook to Healthcare M&A During the Covid-19 Pandemic
The COVID-19 pandemic has stressed the M&A market at every stage of the deal-making process – from complicating on-site visits and intensifying the diligence process to introducing valuation gaps (relative to pre-COVID-19 expectations), complicating purchase agreement negotiations and limiting the availability of debt financing. Despite these hurdles, healthcare dealmakers have continued to pursue attractive acquisition opportunities throughout 2020, with the healthcare M&A market substantially...
By:
Bass, Berry & Sims PLC
Related
Recent enforcement actions by the Federal Trade Commission (FTC or Commission) and the Department of...
Read More >
OSHA’s General Duty Clause requires an employer to provide a workplace free from recognized hazards...
Read More >
This week, over a five-part podcast series, we have considered some of the basic questions around mo...
Read More >
Businesses are starting to reopen as stay-at-home orders and business closures resulting from the no...
Read More >
On May 31, 2019, the U.S. District Court for the Northern District of California awarded a $102 mill...
Read More >
On June 3, 2019, the U.S. Supreme Court ruled that the charge filing requirement under Title VII of ...
Read More >